Logotype for Trisalus Life Sciences Inc

Trisalus Life Sciences (TLSI) investor relations material

Trisalus Life Sciences Piper Sandler 37th Annual Healthcare Conference summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Trisalus Life Sciences Inc
Piper Sandler 37th Annual Healthcare Conference summary2 Dec, 2025

Company overview and technology

  • Focuses on high-margin, high-growth oncology with pressure-enabled drug delivery technology for tumors, improving patient outcomes and reducing impact on normal tissue.

  • Holds over 100 patents, with 20-25 new patents filed annually, and a multi-layered IP portfolio.

  • Addresses the challenge of drug delivery to solid tumors by modulating pressure and flow, increasing drug concentration in tumors by 50%-500%.

  • Technology features a flexible, anti-reflux catheter system that enables homogeneous drug perfusion.

  • Cleared for embolization procedures except in coronary and neurovasculature; expansion possible with further approvals.

Market opportunity and reimbursement

  • Targets a $2.5 billion market, currently with 9% share in liver applications and significant growth potential.

  • Achieved favorable reimbursement, including a proprietary CMS code and $8,000 per catheter pricing, with hospitals saving $8,000 per procedure.

  • Demonstrated 50% reduction in 30-day hospital readmissions and improved patient outcomes, including less fatigue and higher liver transplantation rates.

  • Commercial payers reimburse $20,000-$40,000 per procedure, making it revenue-enhancing for hospitals.

  • Highly concentrated market with 400 hospitals and 1,000 doctors; field force of about 50 people.

Product portfolio and new applications

  • Expanded from two to a full portfolio of devices, enabling treatment of diverse vascular anatomies and new indications.

  • Technology adapted for uterine fibroids, multinodular goiter, and genicular artery embolization, with rapid product development cycles.

  • Uterine fibroid application allows high-flow perfusion and minimally invasive treatment, preserving fertility.

  • Multinodular goiter treatment avoids surgery and preserves thyroid function.

  • Genicular artery embolization delays knee replacement and reduces opioid prescriptions, with potential to transform orthopedics.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Trisalus Life Sciences earnings date

Logotype for Trisalus Life Sciences Inc
Q4 202526 Mar, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Trisalus Life Sciences earnings date

Logotype for Trisalus Life Sciences Inc
Q4 202526 Mar, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Trisalus Life Sciences Inc is an oncology company focused on integrating novel delivery technology with immunotherapy to transform the treatment of patients with liver and pancreatic tumors. The company's approach combines innovative drug delivery systems with clinical-stage investigational immunotherapies, aiming to address the unique challenges of treating tumors in the liver and pancreas. These challenges include overcoming the high intratumoral pressure and immunosuppressive environment that can limit the efficacy of traditional treatments. Trisalus Life Sciences is committed to advancing its platform to improve the therapeutic outcomes for patients facing these difficult-to-treat cancers. The company is headquartered in Denver, Colorado, and its shares are listed on the Nasdaq.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage